Business

U.S. tariffs upend Japanese carmakers’ Mexico gambit–and add to Nissan’s woes


Japanese automakers have long relied on the “dependable and affordable” appeal of their economy cars to drive U.S. sales, thanks in part to low-cost production in Mexico. Now, U.S. President Donald Trump is turning that business model on its head.

Mr. Trump has announced 25% tariffs on auto imports that are due to take effect on April 3. While the longer-term fallout remains unclear, Nissan, Honda, and other carmakers may need to raise sticker prices, industry experts say, including on economy models that target the most price-sensitive buyers.

It is another big headache particularly for troubled Nissan, given its reliance on both the U.S. market and Mexican production.

Last year, major Japanese carmakers exported almost 880,000 vehicles to the United States from Mexico, according to data from Mexico’s national statistics agency. While Toyota’s Tacoma pick-up was the most exported model, Nissan had the biggest share of any automaker, accounting for more than a third, with 327,000 vehicles, the data showed.

The Sentra was Nissan’s most exported model, with 180,000 of the compact sedans going across the border. The car starts at $21,590, according to Nissan’s website.

“The reason cars are made in Mexico is because costs are cheap, allowing automakers to produce economy vehicles there. A lot of those cars being made in Mexico are models where it is difficult to raise the prices, or if you do, you can only raise the price by a little,” said Koji Endo, head of equities research at SBI Securities.

In one scenario, Goldman Sachs sees tariff-related price hikes depressing Japanese automakers’ sales and operating profits in the current financial year.

Mazda could see the biggest hit with a 59% profit reduction, with Nissan next with an estimated 56% drop, according to Goldman estimates. Toyota, the world’s top-selling carmaker, would see a 6% decline and Honda would take an 8% hit.

That is especially bad news for Nissan, which is already flailing in the United States due to an ageing line-up and lack of hybrid models.

It cut its profit forecast three times in the financial year just ended and has had its debt downgraded to “junk”.

Nissan’s new chief executive, 46-year-old Ivan Espinosa, a Mexican national who was earlier its planning boss, has promised to dramatically cut the time it takes the company to develop new cars. Slow decision-making at Nissan was one of the reasons why its merger talks with Honda collapsed in February, Reuters has previously reported.

Nissan declined to comment on its plans to deal with tariffs.

Toyota, which benefits from a diverse line-up that spans trucks and Lexus luxury vehicles, has said it plans to maintain “current operations for the time being” in regard to pricing and tariffs.

Honda declined to comment on Mr. Trump’s tariff announcement directly, saying it will consider minimising cross-border supplies within North America. It said it might need to consider restructuring its production network and supply chain if the U.S. keeps tariffs in place over the long term.

The automaker plans to make its next-generation Civic hybrid in the U.S. state of Indiana, instead of Mexico, to avoid potential tariffs, people familiar with its plans told Reuters last month.

Trading down

James Hong, head of mobility research at Macquarie, reckons tariffs, if fully passed on to consumers, would mean in practice an increase of 20% because duties are calculated on the vehicle transfer price, rather than the retail price.

Still, 20% is a considerable sticker shock for Sentra buyers already grappling with inflation.

Most automakers are unable to shift production from Mexico to the United States either, because they now lack spare production capacity in the U.S., Hong said.

Instead, it is more likely that consumers will trade down, including to the used car market, which could also see price increases.

Around 27% of Nissan’s U.S. sales originate from Mexico, compared to some 13% at Honda and 8% at Toyota, according to S&P Global Mobility.

Nissan has been producing cars in Mexico since 1966, when it opened its first manufacturing plant outside Japan. Toyota, Honda and Mazda later followed. Nissan’s first U.S. plant opened in Smyrna, Tennessee, in 1983.

Global automakers have helped Mexico become the top exporter to the United States with $476 billion worth of goods shipped in 2023, according to IMF data. In 1966, the year Nissan set up shop, Mexico was at No.6 with $824 million in exports, the data showed.

Saved by the yen

Japan’s weak yen currency may prove to be, yet again, a saving grace for the automakers, increasing profits when earnings from abroad are brought home.

Given that Japanese automakers tend to plan in multi-year cycles, cars imported into the United States are being sold at prices that, in yen terms, are considerably higher than three years ago, when they likely set the parameters for the current cycle, said Seiji Sugiura, an analyst at Tokai Tokyo Intelligence Laboratory.

The yen was trading at around 150 to the dollar on Wednesday, compared with 122 three years ago.

“If this current level of around 150 yen to the dollar continues for a time, they can still make a profit even with 25% tariffs,” Mr.. Sugiura said.

Automakers may also choose to raise prices of some models rather than across the board, said Ken Miyao, CEO of research company Carnorama Japan.

Nissan has drawn up several scenarios that it can use once tariff policies are clear, CEO Espinosa said last week.

Given Nissan’s finances, it may be the first to act, Mr. Miyao said. “Nissan may not have a choice and may have to raise prices first.”



Source link

Microsoft founder Bill Gates reflects upon a 50-year-old computer code that reshaped technology


After spending two months, Gates finished the code that became the basis for the Altair’s first operating system [File]

After spending two months, Gates finished the code that became the basis for the Altair’s first operating system [File]
| Photo Credit: REUTERS

Even as he grows older, Microsoft founder Bill Gates still fondly remembers the catalytic computer code he wrote 50 years ago that opened up a new frontier in technology.

Although the code that Gates printed out on a teletype machine may look crude compared to what’s powering today’s artificial intelligence platforms, it played a critical role in creating Microsoft in April 1975 — a golden anniversary that the Redmond, Washington, company will celebrate on Friday.

Gates, 69, set the stage for that jubilee with a blog post reminiscing on how he and his old high school friend — the late Paul Allen — scrambled to create the world’s first “software factory” after reading an article in the January 1975 issue of Popular Electronics magazine about the Altair 8800, a minicomputer that would be powered by a tiny chip made by the then-obscure technology company, Intel.

The article inspired Gates, who was just a freshman at Harvard University, and Allen to call Altair’s maker, Micro Instrumentation and Telemetry Systems, and promise the company’s CEO Ed Roberts they had developed software that would enable consumers to control the hardware. There was just one hitch: Gates and Allen hadn’t yet come up with the code they promised Roberts.

Gates and Allen tackled the challenge by latching onto the BASIC computer language that had been developed in 1964 at Dartmouth College, but they still had to figure out a way to make the technology compatible with the forthcoming Altair computer, even though they didn’t even have a prototype of the machine.

After spending two months working on the program with little sleep, Gates finished the code that became the basis for the Altair’s first operating system. “That code remains the coolest I’ve ever written,” Gates wrote in his blog post, which includes an option to download the original program.

The code would go on to provide the foundation for a business that would make personal computers a household staple, with a suite of software that include the Word, Excel and PowerPoint programs, as well as the Windows operating system that still powers most PCs today.

“That was the revolution,” Gates said of the code in a video accompanying his post. “That was the thing that ushered in personal computing.”

Gates’ recollection of the code is part of a nostalgic kick that he has been on this year as he prepares to turn 70 in October.

The trip down memory lane included the February release of a memoir exploring his early years as an often-misunderstood child with few friends, and a hailing of the 25th anniversary of the philanthropic foundation he created after stepping down as Microsoft’s CEO in 2000. The tech giant initially stumbled after Gates’ departure but has been thriving under CEO Satya Nadella, and has amassed a market value of about $2.8 trillion.

In his memoir, Gates also reflected on his tempestuous relationship with fellow PC pioneer, the late Apple co-founder Steve Jobs, whose company will be celebrating its golden anniversary next year.

“Fifty years is a long time,” said Gates, whose personal fortune is estimated at $108 billion. “It’s crazy that the dream came true.”



Source link

Tariff to hit merchandise, agri exports to U.S.; trade calls for early conclusion of BTA between India and U.S.


Exporters in India have called for early conclusion of bilateral trade agreement (BTA) with the U.S. File (Representational image)

Exporters in India have called for early conclusion of bilateral trade agreement (BTA) with the U.S. File (Representational image)
| Photo Credit: Reuters

In the wake of the U.S. announcing 26% tariff on its Indian imports, exporters in India have called for early conclusion of bilateral trade agreement (BTA) with the U.S.

“Assessing the impact of the recently imposed 26% reciprocal tariffs by the United States on Indian exports reveals a nuanced scenario. While these tariffs do present challenges, India’s position remains comparatively favourable. For instance, Vietnam faces a 46% tariff, China 34%, and Indonesia 32%, placing India in a relatively better position than key competitors such as Vietnam, China, Indonesia, Bangladesh, Sri Lanka, and Myanmar. Despite the tariffs, certain sectors in India, including apparel, gems and jewellery, leather, electronics, chemicals, plastics, and furniture, may experience a diversion of exports, potentially offsetting some adverse effects. The timely conclusion of a Bilateral Trade Agreement (BTA) between India and the U.S. is crucial to mitigate these tariffs and provide relief to Indian exporters,” said Ajay Sahai, director general and chief executive officer of Federation of Indian Exporters Organisation (FIEO).

The executive director of EEPC India Adhip Mitra said, engineering exports to the U.S. — valued at $17 billion in FY 24 — is likely to decline to $11.3 billion to $12.8 billion because of the 27% tariff. Indian export of steel and steel products, aluminium and products, auto components, electrical machinery and equipment and industrial machinery will be the worst hit. India should accelerate its efforts for trade agreements with the EU, UK, Canada and the GCC. Strategic intervention will give relief to exporters, he added.

According to Siddhartha Rajagopal, executive director of the Cotton Textiles Export Promotion Council, supply of garments and textiles to the U.S. from Asia will take a hit with the tariffs announced by the US. The fulcrum of production is likely to shift to south America, parts of Europe and Turkey in the short term. Labour-intensive Indian industries such as garments and home textiles should get a good deal in the proposed bilateral trade agreement between India and the US, he noted.

Rice exporters are of the view that the trade will be able to manage the tariff as most of the rice consumers in the U.S. are Indian diaspora and rice is an essential commodity.



Source link

U.S. tariff exemption: Indian pharma companies’ stocks get a boost


Image used for representation purpose only.

Image used for representation purpose only.
| Photo Credit: Getty Images/iStock Photo

Indian pharma stocks were in focus on Thursday (April 3, 2025) early trading hours after the generic drugmakers got an exemption from U.S. tariff levy.

Also read: Front-end manufacturing in U.S. way forward to counter tariff impact on pharma: Natco Pharma CEO

Aurobindo Pharma, Dr. Reddy’s Laboratories, Sun Pharma, Lupin, Cipla, Natco Pharma, Gland Pharma were among the shares on the upswing. All the 20 entities part of the Nifty Pharma were in green even as the sectoral index of National Stock Exchange showed a 2.92% increase around 10.30 a.m. It was higher soon after market opening.

Organisations representing pharma firms and exporters hailed the development around U.S. tariff for their industry. Pharmaceuticals Export Promotion Council of India welcomed the tariff exemption. The move reaffirms commitment to uninterrupted supply of quality and affordable medicines, the body under the Commerce Ministry said.

“Pharmexcil welcomes U.S. tariff exemption… express our gratitude to the government of India for successfully negotiating exemption of Indian pharmaceuticals from U.S. reciprocal tariffs. This vital decision secures uninterrupted flow of essential and affordable medicines to Americans reinforcing India’s unwavering commitment to quality and reliable supply. Indian pharmaceutical industry is dedicated to strengthening the India-U.S. healthcare partnership, ensuring continued access to life-saving treatments…” chairman Namit Joshi said.

Separately, Pharmexcil director general Raja Bhanu said “We thank the Ministry of Commerce for having extensive and elaborate discussions with U.S. counterparts to ensure pharmaceuticals are exempted. The industry will ensure the seamless supply of quality and affordable medicines which is its U.S.P. …continue to do so for the healthcare needs of U.S.A.”

Win-win scenario

It is win-win scenario because of the seamless supply of quality and affordable medicines to Americans reducing the healthcare costs to a great extent, he said.

Indian Pharmaceutical Alliance (IPA) secretary general Sudarshan Jain said pharmaceuticals getting exempted from the tariff underscores the critical role of cost-effective, life-saving generic medicines in public health, economic stability and national security. He said pharmaceuticals remain a cornerstone in the overall India-U.S. bilateral trade that the two countries have agreed to double to $500 billion.

The development is bound to come as a big relief for the industry, at least for time being. Commenting on the tariffs announced by the U.S. and bound to impact various industries, head of global equities at Marcellus Investment Managers Arindam Mandal said, “The announced tariffs are more severe than anticipated. There are some temporary exemptions though — such as for pharmaceuticals, semiconductors, and energy — but their impact may be limited.”

In the run up to the tariff announcement and as a measure to soften the blow, Indian pharma began evaluating even some manufacturing in the U.S. Getting a front-end manufacturing in the U.S. was the only way forward in the event of U.S. levying tariff on pharmaceuticals, Natco Pharma’s vice-chairman and CEO Rajeev Nannapaneni had said. Setting the backdrop for his observation, during an investor call, was the U.S. president Donald Trump threatening to levy 25% reciprocal tariff on Indian pharma. India levies 10% tariff on U.S. pharma imports.



Source link

Pharma companies’ stocks get a boost on U.S. tariff exemption


Image used for representation purpose only.

Image used for representation purpose only.
| Photo Credit: Getty Images/iStock Photo

Indian pharma stocks were in focus on Thursday (April 3, 2025) early trading hours after the generic drugmakers got an exemption from U.S. tariff levy.

Also read: Front-end manufacturing in U.S. way forward to counter tariff impact on pharma: Natco Pharma CEO

Aurobindo Pharma, Dr. Reddy’s Laboratories, Sun Pharma, Lupin, Cipla, Natco Pharma, Gland Pharma were among the shares on the upswing. All the 20 entities part of the Nifty Pharma were in green even as the sectoral index of National Stock Exchange showed a 2.92% increase around 10.30 a.m. It was higher soon after market opening.

Organisations representing pharma firms and exporters hailed the development around U.S. tariff for their industry. Pharmaceuticals Export Promotion Council of India welcomed the tariff exemption. The move reaffirms commitment to uninterrupted supply of quality and affordable medicines, the body under the Commerce Ministry said.

“Pharmexcil welcomes U.S. tariff exemption… express our gratitude to the government of India for successfully negotiating exemption of Indian pharmaceuticals from U.S. reciprocal tariffs. This vital decision secures uninterrupted flow of essential and affordable medicines to Americans reinforcing India’s unwavering commitment to quality and reliable supply. Indian pharmaceutical industry is dedicated to strengthening the India-U.S. healthcare partnership, ensuring continued access to life-saving treatments…” chairman Namit Joshi said.

Separately, Pharmexcil director general Raja Bhanu said “We thank the Ministry of Commerce for having extensive and elaborate discussions with U.S. counterparts to ensure pharmaceuticals are exempted. The industry will ensure the seamless supply of quality and affordable medicines which is its U.S.P. …continue to do so for the healthcare needs of U.S.A.”

Win-win scenario

It is win-win scenario because of the seamless supply of quality and affordable medicines to Americans reducing the healthcare costs to a great extent, he said.

Indian Pharmaceutical Alliance (IPA) secretary general Sudarshan Jain said pharmaceuticals getting exempted from the tariff underscores the critical role of cost-effective, life-saving generic medicines in public health, economic stability and national security. He said pharmaceuticals remain a cornerstone in the overall India-U.S. bilateral trade that the two countries have agreed to double to $500 billion.

The development is bound to come as a big relief for the industry, at least for time being. Commenting on the tariffs announced by the U.S. and bound to impact various industries, head of global equities at Marcellus Investment Managers Arindam Mandal said, “The announced tariffs are more severe than anticipated. There are some temporary exemptions though — such as for pharmaceuticals, semiconductors, and energy — but their impact may be limited.”

In the run up to the tariff announcement and as a measure to soften the blow, Indian pharma began evaluating even some manufacturing in the U.S. Getting a front-end manufacturing in the U.S. was the only way forward in the event of U.S. levying tariff on pharmaceuticals, Natco Pharma’s vice-chairman and CEO Rajeev Nannapaneni had said. Setting the backdrop for his observation, during an investor call, was the U.S. president Donald Trump threatening to levy 25% reciprocal tariff on Indian pharma. India levies 10% tariff on U.S. pharma imports.


https://www.thehindu.com/business/front-end-manufacturing-in-us-way-forward-to-counter-tariff-impact-on-pharma-natco-pharma-ceo/article69243853.ece  

EOM



Source link

Donald Trump reciprocal tariffs: Why India’s agricultural exports are likely to be little affected


Donald Trump reciprocal tariffs: Why India’s agricultural exports are likely to be little affected
Trump’s tariffs on Indian products would have a restricted impact on crucial agricultural exports.

India may sustain or potentially increase its agricultural exports to the United States, despite US President Donald Trump’s new reciprocal tariff implementation, according to distinguished agricultural economist Ashok Gulati.
The Trump administration’s 26 per cent “discounted reciprocal tariff” on Indian products would have a restricted impact on crucial agricultural exports like seafood and rice compared to higher duties levied on regional competitors, said Gulati, who previously chaired the Commission for Agricultural Costs and Prices (CACP).
“We should not look at the tariff increase in absolute terms, but see relative tariff increases with our competitors,” Gulati told PTI.

  • He highlighted that whilst India faces 26 per cent tariffs, China encounters 34 per cent, providing Indian exporters an 8 per cent comparative advantage.
  • Additional competitors encounter higher barriers: Vietnam at 46 per cent, Bangladesh 37 per cent, Thailand 36 per cent, and Indonesia at 32 per cent.

Regarding seafood exports, particularly shrimp, Gulati explained that India’s comparative tariff advantage, coupled with shrimp’s minimal share in overall US food expenditure, suggests demand should remain stable.
Also Read | Donald Trump announces 26% ‘discounted’ reciprocal tariff on India: What will be the impact and is Indian economy relatively insulated?
Shrimp Feed Manufacturers Association of India’s general secretary, Gulrej Alam, indicated that India exports approximately half of its total annual 9 lakh tonnes of shrimp to the US.
“There will be a little setback in the short term because of a lower tariff of 10 per cent imposed on Ecuador, which is also one of the major shrimp exporters to America,” Alam said, noting this development concerns Indian shrimp production.
Ecuador benefits from its proximity to the US. Nevertheless, India possesses superior bulk handling capacity and packaging quality, Alam observed.
“In the short term, the trade will see re-routing. However, in the long term, trade will not be a challenge,” he added.
Regarding rice exports, where current US tariffs are 9 per cent, India maintains competitiveness against Vietnam and Thailand despite the increase to 26 per cent.
Also Read | TOI Explainer: How India may gain from Trump’s tariffs
All India Rice Exporters Association’s former president, Vijay Sethia, stated India exports 250,000 to 300,000 tonnes of rice yearly to the US.
“The 26 per cent tariff on all varieties of rice will definitely slow down our exports in the short term but will capture its space in the long term,” Sethia said, adding that the duty increase would affect American consumers.
Gulati, currently chair professor for agriculture at the Indian Council for Research on International Economic Relations (ICRIER), indicated India could potentially secure market share in sectors vacated by competitors facing higher tariffs.





Source link

South Western Railway achieves growth in various segments, revenue goes up


In October 2024, SWR began container loading operations at Sambre railway station in Belagavi district of Karnataka. SWR recorded a total freight loading of 45.66 million tonnes (MT) in FY 2024-25, out of which, Hubballi division contributed the maximum (32.69 MT) while Mysuru division contributed 10.89 MT

In October 2024, SWR began container loading operations at Sambre railway station in Belagavi district of Karnataka. SWR recorded a total freight loading of 45.66 million tonnes (MT) in FY 2024-25, out of which, Hubballi division contributed the maximum (32.69 MT) while Mysuru division contributed 10.89 MT
| Photo Credit: Special Arrangement

During the financial year 2024-25 that just concluded, South Western Railway (SWR) has achieved significant milestones in freight loading, revenue generation, and infrastructure development.

Chief Public Relations Officer Manjunath Kanamadi has said that SWR demonstrated substantial growth across various revenue streams during the financial year.

While passenger revenue surged to ₹3,172.82 crore from ₹3,090.5 crore during the previous fiscal, other coaching revenue rose to ₹335.24 crore from ₹328.26 crore, and parcel revenue went up to ₹166.6 crore from to ₹157.77 crore last year.

The gross revenue of SWR reached ₹8,340.90 crore during the fiscal, and commercial sundry revenue reached ₹91.60 crore from ₹78.90 crore during the previous year.

The passenger traffic witnessed growth, with 165.51 million travellers during the year. Last year, it was 162.16 million.

SWR recorded a total freight loading of 45.66 million tonnes (MT) in FY 2024-25, out of which, Hubballi division contributed the maximum (32.69 MT) while Mysuru division contributed 10.89 MT

In March 2025, SWR reached its highest monthly originating freight loading of 5.024 MT and it also recorded highest-ever originating mineral oil loading of 2.56 MT during the year. Additionally, a record 3,870 eight-wheeler units were loaded in a single day, the highest recorded during the fiscal.

The zone also achieved a new milestone in steel loading on March 31, with 29 rakes and 1,539 units loaded in a single day, setting an all-time high.

In terms of infrastructure development, electrification of 67.57 route kilometres was completed, bringing the total electrified route length to 3,323 km out of 3,692 km under the railway zone. During the year, the zone successfully commissioned 26.5 km of new railway lines, and completed 39.1 km of double lines.



Source link

KVGB launches e-Bank Guarantee services in Dharwad


Chairman of Karnataka Vikas Gramin Bank Shrikant M. Bhandiwad launching e-Bank Guarantee (e-BG) services in Dharwad on April 2, 2025.

Chairman of Karnataka Vikas Gramin Bank Shrikant M. Bhandiwad launching e-Bank Guarantee (e-BG) services in Dharwad on April 2, 2025.
| Photo Credit: SPECIAL ARRANGEMENT

Regional rural bank (RRB) Karnataka Vikas Gramin Bank (KVGB) launched its e-Bank Guarantee (e-BG) services in collaboration with the government’s information utility provider National E-Governance Services Limited (NESL) in Dharwad on April 2.

Launching the services in Dharwad, bank Chairman Shrikant M. Bhandiwad said that KVG Bank is the first among the 43 regional rural banks in India to introduce the facility.

“The e-BG service leverages e-signatures and e- stamps, significantly simplifying the bank guarantee process. With this facility, guarantees can now be issued within minutes. Beneficiaries can view the e-Bank Guarantee on the NESL portal immediately after issuance, eliminating the need for additional confirmation,” he said.

Mr. Bhandiwad said that, apart from enhancing transparency in banking transactions, the new services would greatly benefit customers, specially in semi-urban and rural areas.

He announced that KVGB has achieved a turnover of ₹38,514 crore durng 2024-25, reflecting a 7.32% growth.

KVGB’s General Manager (IT) Malachi Punith explained the features of the e-BG facilities.



Source link

Cheer on reciprocal tariffs! Donald Trump spares India’s pharmaceutical industry


Cheer on reciprocal tariffs! Donald Trump spares India’s pharmaceutical industry
The US market represents 30% of Indian pharmaceutical exports. (AI image)

US President Donald Trump has provided significant relief to India’s pharmaceutical sector by excluding pharmaceuticals from the new reciprocal tariffs regulation on Thursday.
“Some goods will not be subject to the Reciprocal Tariff. These include: (1) articles subject to 50 USC 1702(b); (2) steel/aluminum articles and autos/auto parts already subject to Section 232 tariffs; (3) copper, pharmaceuticals, semiconductors, and lumber articles; (4) all articles that may become subject to future Section 232 tariffs; (5) bullion; and (6) energy and other certain minerals that are not available in the United States,” the White House said in a factsheet.
The US market represents 30% of Indian pharmaceutical exports.
Also Read | Donald Trump announces 26% ‘discounted’ reciprocal tariff on India: What will be the impact and is Indian economy relatively insulated?
The sector responded positively to this decision, noting its significance for affordable generic medicines in healthcare, economic stability and national security.
“India and the U.S. share a strong and growing bilateral trade relationship, with a shared vision to double trade to $500 billion under the Mission 500 initiative. Pharmaceuticals remain a cornerstone of this partnership, as India plays a vital role in global and U.S. healthcare by ensuring a steady supply of affordable medicines,” said Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance (IPA).
Also Read | TOI Explainer: India likely to gain as Trump tariff shake-up hits Asia
The White House noted that India implements particularly demanding and redundant testing and certification requirements in areas including chemicals, telecom products, and medical devices, creating obstacles for American companies in the Indian market.
“If these barriers were removed, it is estimated that U.S. exports would increase by at least $5.3 billion annually,” according to the factsheet.





Source link

Markets decline in early trade, tracking weak Asian peers on Trump’s tariffs announcement


A bird flies past a screen displaying the Sensex results on the facade of the Bombay Stock Exchange (BSE) building in Mumbai.

A bird flies past a screen displaying the Sensex results on the facade of the Bombay Stock Exchange (BSE) building in Mumbai.
| Photo Credit: REUTERS

Equity benchmark indices Sensex and Nifty declined in early trade on Thursday (April 3, 2025) dragged down by IT stocks, weak trends from Asian markets after the U.S. has announced reciprocal tariffs on about 60 countries.

The U.S. has announced 27% reciprocal tariffs on India, saying New Delhi imposes high import duties on American goods, as the Donald Trump administration aims to reduce the country’s trade deficit and boost manufacturing.

The move is expected to impact India’s exports to the U.S. However, experts say that India is better-placed than its competitors, who also face increased levies.

The 30-share BSE Sensex decreased 378.60 points or 0.49% to 76,238.84 in the morning trade. In the session, it depreciated by 809.89 points or 1.05% to hit an intraday low of 75,807.55.

The broader NSE Nifty slipped 80.60 points or 0.35% to 23,251.75.

From the Sensex pack, Tata Consultancy Services, Infosys, Tech Mahindra, HCL Technologies, Tata Motors, Adani Ports, Bharti Airtel, Reliance Industries and Maruti Suzuki, Zomato and Kotak Mahindra Bank were the major laggards.

Sun Pharmaceuticals, NTPC, Titan, PowerGrid, Bajaj Finance, UltraTech Cement, Asian Paints, IndusInd Bank, and Larsen & Toubro were among the gainers. The BSE midcap gauge depreciated 0.41%, and the smallcap index dipped 0.08%.

In Asian markets, Tokyo’s Nikkei plunged the most by more than 3%, followed by Hong Kong (2%), Seoul’s KOSPI (1 %) and Shanghai (0.39%).

According to HDFC Securities’ Head of Prime Research Devarsh Vakil, Global stock markets plunged after U.S. President Donald Trump announced harsher-than-expected tariffs.

On Wednesday (April 2, 2025), Mr. Trump laid out the U.S. “reciprocal tariff” rates that more than 180 countries and territories, including European Union members, will face under his sweeping new trade policy.

The U.S. markets ended higher in overnight deals on Wednesday.

Global oil benchmark Brent crude dipped 2.31% to $73.22 a barrel.

Meanwhile, foreign Institutional Investors (FIIs) offloaded equities worth ₹1,538.88 crore on Wednesday, while Domestic Institutional Investors (DIIs) outnumbered the FIIs by purchasing equities worth ₹2,808.83 crore.

On Wednesday, the 30-share BSE Sensex rebounded 592.93 points to settle at 76,617.44, and the NSE Nifty climbed 166.65 points to settle at 23,332.35.



Source link